Several studies have linked chronic inflammation signaling through the TLR-IRAK pathways to the induction of genetic alterations/instability, tumor initiation, tumor promotion, and tumor progression, including tumor invasion, metastasis, and therapy resistance [223,224,225]. The gene discussed is IRAK1; the disease is neoplasm.